In the race to find an effective treatment for COVID-19, Artificial Intelligence may end up playing a big role because of its ability to quickly test drug combinations -- as in testing up to a trillion different combinations in a matter of weeks. Dr. Dean Ho, Director of the Institute for Digital Medicine at National University of Singapore, explains the fascinating capabilities of AI to to test and rank drug cocktails while taking safety and underlying patient conditions into account in this interview with Dr. Rishi Desai. If you like this podcast, please share it on your social channels. You
can also subscribe to the series and check out all of our episodes at
www.osmosis.org/podcast
Raise the Line